Synthesis, in vitro evaluation, and molecular modeling of Donepezil-inspired N-benzylpiperidine–phenolic conjugates as dual-action acetylcholinesterase inhibitors with antioxidant properties


ÇOBANOĞLU O., İLKAR ERDAĞI S., Alici E. H., Akin M., ŞAKİ N., Arabaci G., ...Daha Fazla

Journal of Molecular Structure, cilt.1353, 2026 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1353
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.molstruc.2025.144684
  • Dergi Adı: Journal of Molecular Structure
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, Chimica, Compendex, INSPEC
  • Anahtar Kelimeler: Acetylcholinesterase inhibition, Antioxidant activity, Donepezil, Molecular docking, N–benzylpiperidine, Phenolic acid conjugates
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Alzheimer's disease (AD) is associated with multiple pathological processes, including cholinergic deficits and oxidative stress, which together motivate the search for multifunctional agents. In this study, we designed and synthesized a series of N–benzylpiperidine–phenolic acid conjugates that combine the AChE-inhibitory pharmacophore of Donepezil with antioxidant scaffolds. Structural characterization was confirmed by NMR and HRMS. The compounds were evaluated through in vitro AChE inhibition and antioxidant assays, complemented by molecular docking studies. Among the series, PD8 displayed the most potent AChE inhibition (IC50 = 2.38 µM), while PDD4 exhibited the strongest antioxidant effect in the DPPH assay (66.8% at 50 µM). MD simulations further demonstrated that PD8 maintained conformational stability in the AChE active site with a stronger hydrogen bonding profile compared to Donepezil, thereby reinforcing the docking results. These results indicate that methoxy substitution patterns, particularly in PD8, play a decisive role in enhancing AChE activity, whereas hydroxyl-rich scaffolds favor antioxidant effects. Collectively, the findings highlight the potential of benzylpiperidine–phenolic hybrids as tractable chemical scaffolds for further optimization. Future studies will focus on expanding their biological evaluation, including BuChE selectivity and cellular assays, to better establish their therapeutic relevance.